AXSM (STOCKS)
Axsome Therapeutics, Inc
$184.910000
+0.610000 (+0.33%)
Prev close: $184.300000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Herriott Tabuteau
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $9,411.16M
- Employees
- 816
- P/E (TTM)
- -39.44
- P/B (TTM)
- 125.76
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $561.26M |
| Benefits Costs and Expenses | $791.67M |
| Costs And Expenses | $773.69M |
| Operating Expenses | $773.69M |
| Selling, General, and Administrative Expenses | $514.57M |
| Research and Development | $189.49M |
| Other Operating Expenses | $69.62M |
| Operating Income/Loss | -$212.42M |
| Income/Loss From Continuing Operations After Tax | -$229.53M |
| Income/Loss From Continuing Operations Before Tax | -$230.40M |
| Income Tax Expense/Benefit | -$875.00K |
| Interest Expense, Operating | -$18.15M |
| Net Income/Loss | -$229.53M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$229.53M |
| Net Income/Loss Available To Common Stockholders, Basic | -$229.53M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.67 |
| Diluted Earnings Per Share | -$4.67 |
| Basic Average Shares | 49,659,965 |
| Diluted Average Shares | 49,659,965 |
| Assets | $669.25M |
| Current Assets | $565.34M |
| Inventory | $23.77M |
| Other Current Assets | $541.57M |
| Noncurrent Assets | $103.91M |
| Fixed Assets | $605.00K |
| Intangible Assets | $42.13M |
| Other Non-current Assets | $61.18M |
| Liabilities | $595.52M |
| Current Liabilities | $360.29M |
| Accounts Payable | $54.23M |
| Wages | $27.80M |
| Other Current Liabilities | $278.27M |
| Noncurrent Liabilities | $235.23M |
| Equity | $73.73M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $73.73M |
| Liabilities And Equity | $669.25M |
| Net Cash Flow From Operating Activities | -$100.95M |
| Net Cash Flow From Operating Activities, Continuing | -$100.95M |
| Net Cash Flow From Investing Activities | -$439.00K |
| Net Cash Flow From Investing Activities, Continuing | -$439.00K |
| Net Cash Flow From Financing Activities | $99.32M |
| Net Cash Flow From Financing Activities, Continuing | $99.32M |
| Net Cash Flow | -$2.07M |
| Net Cash Flow, Continuing | -$2.07M |
| Comprehensive Income/Loss | -$229.53M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$229.53M |
| Other Comprehensive Income/Loss | $0.00 |